Nazende GündayTüreli
246 posts
Postdoc, PhD and Technician positions available @UniklinikAachen and @RWTH. Join our diverse and dynamic team to work on translational aspects of cancer nanomedicine and nano-immunotherapy. Projects funded by @dfg_public and @ERC_Research. Contact via email or DM. Pls retweet 🙏
Attn industry, R&D&I sector, regulatory agencies, clinics, and patients! Save the date for our joint stakeholder workshop: "Nano2Clinic – Synergies for Clinical Translation of #Nanotechnology in #Cancer Therapies" on 3 March in #Zagreb. phoenix-oitb.eu/nano-to-clinic…
Lipid-based #nanoparticles can be functionalized to target certain areas of the body for drug delivery, making medications work more quickly and effectively in lower doses: “smart” drug delivery systems. They are well-tolerated and have lower toxicity than other nanoparticles. 💉
OPEN CALL for funded services in #nanopharmaceutical development: ♦️Physico-Chemical, ♦️In vitro & ♦️In vivo Characterisation; ♦️Manufacturing Legal entities & research groups based in 🇪🇺/#H2020 associate countries may apply. Apply by 31 Jan 2023! ➡️phoenix-oitb.eu/open-call/
OPEN CALL for funded services in #nanopharmaceutical development: ♦️Physico-Chemical, ♦️In vitro & ♦️In vivo Characterisation; ♦️Manufacturing Legal entities & research groups based in 🇪🇺/#H2020 associate countries may apply. Apply by 31 Jan 2023! ➡️phoenix-oitb.eu/open-call/
The #ETERNAL project held a successful kick-off meeting in Valencia last week. AIMPLAS coordinates this four-year Horizon Europe project to boost reduction of the environmental impact of pharmaceutical products through their entire life cycle. bit.ly/3fHAP5V
